EQ-5D
≈ 7 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
EQ-5D is a standardised measure of health-related quality of life developed by the EuroQol Group to provide a simple, generic questionnaire for use in clinical and economic appraisal and population health surveys. EQ-5D assesses health status in terms of five dimensions of health and is considered a 'generic' questionnaire because these dimensions are not specific to any one patient group or health condition. EQ-5D can also be referred to as a patient-reported outcome (PRO) measure, because patients can complete the questionnaire themselves to provide information about their current health status and how this changes over time. 'EQ-5D' is not an abbreviation and is the correct term to use when referring to the instrument in general. EQ-5D is widely used around the world in clinical trials and real-world clinical settings, population studies, and health economic evaluations. By mid-2020, the number of EQ-5D studies registered with the EuroQol Group totalled over 39,000. These comprised over 80 clinical areas and related to surgical procedures, hospital waiting lists, physiotherapy, general practice and primary care, and rehabilitation. The number of annual requests to use EQ-5D is approximately 5000, and EQ-5D data have been reported in over 8000 peer-reviewed papers over the past 30 years. EQ-5D can be used for a variety of purposes.…
EQ-5D is a standardised measure of health-related quality of life developed by the EuroQol Group to provide a simple, generic questionnaire for use in clinical and economic appraisal and population health surveys. EQ-5D assesses health status in terms of five dimensions of health and is considered a 'generic' questionnaire because these dimensions are not specific to any one patient group or health condition. EQ-5D can also be referred to as a patient-reported outcome (PRO) measure, because patients can complete the questionnaire themselves to provide information about their current health status and how this changes over time. 'EQ-5D' is not an abbreviation and is the correct term to use when referring to the instrument in general. EQ-5D is widely used around the world in clinical trials and real-world clinical settings, population studies, and health economic evaluations. By mid-2020, the number of EQ-5D studies registered with the EuroQol Group totalled over 39,000. These comprised over 80 clinical areas and related to surgical procedures, hospital waiting lists, physiotherapy, general practice and primary care, and rehabilitation. The number of annual requests to use EQ-5D is approximately 5000, and EQ-5D data have been reported in over 8000 peer-reviewed papers over the past 30 years. EQ-5D can be used for a variety of purposes. In clinical trials and routine clinical settings, EQ-5D can be used (i) to provide a profile of patient health on the day of questionnaire completion; (ii) to monitor the health status of patient groups at particular times, e.g. at referral, admission, discharge, and follow-up; and (iii) to measure changes in health status over time in individual patients and in cohorts of patients, such as before and after health interventions and treatments. In population studies, EQ-5D can be used to assess population health status at local and national levels and to follow population health status over time. In medical decision-making, EQ-5D can be used (i) to measure the impacts and outcomes of healthcare services; (ii) to provide relevant information for the economic evaluation of health programmes and policies; and (iii) to assist in providing evidence about effectiveness in processes where drugs or procedures require approval. EQ-5D is recommended by many health technology assessment (HTA) bodies internationally as a key component of cost-utility analyses. EQ-5D was developed by the EuroQol Group, and its distribution and licensing are managed by the EuroQol Research Foundation.
EQ-5D-3L
In EQ-5D-3L, the five dimensions each have three response levels of severity. The mobility dimension ranges from 'I have no problems walking about' to 'I am confined to bed'. The self-care dimension ranges from 'I have no problems with self-care' to 'I am unable to wash or dress myself'. The usual activities dimension concerns work, study, housework, family, or leisure activities and ranges from 'I have no problems doing my usual activities' to 'I am unable to do my usual activities'. The pain/discomfort dimension ranges from 'I have no pain or discomfort' to 'I have extreme pain or discomfort'. The anxiety/depression dimension ranges from 'I am not anxious or depressed' to 'I am extremely anxious or depressed'. Respondents are asked to choose the statement in each dimension that best describes their health status on the day they are surveyed. Their responses are coded as a number (1, 2, or 3) that corresponds to the respective level of severity: 1 indicates no problems, 2 some problems and 3 extreme problems. In this way, a person's health state profile can be defined by a 5-digit number, ranging from 11111 (having no problems in any of the dimensions) to 33333 (having extreme problems in all the dimensions). The health state 12321 would indicate a person having no problems with mobility, having some problems with self-care, being unable to perform their usual activities, having some pain or discomfort and not being anxious or depressed. In total, the EQ-5D-3L describes 243 (=3⁵) potential health states. EQ-5D-5L was introduced in 2009 with the aim of enhancing instrument sensitivity and providing respondents with the opportunity to provide a more detailed and accurate picture of their health. The EQ-5D-5L descriptive system uses the same five dimensions as the EQ-5D-3L but has two extra levels of severity in each dimension. The five levels in each dimension are worded as (1) 'not /no problems', (2) 'slight problems', (3) 'moderate problems', (4) 'severe problems' and (5) 'unable to' (mobility, self-care, usual activities), 'extreme' (pain/depression), or 'extremely' (anxiety/depression). A few changes in the wording of some levels were also made. For example, in the mobility dimension, the 3L term 'confined to bed' has been replaced with 'unable to walk about' in the 5L; and the first level of self-care in the 5L now refers to washing and dressing, to be consistent with the other levels. Because of the additional levels in EQ-5D-5L, the descriptive system describes 3125 (=5⁵) potential health states.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1372737303 under CC BY-SA 4.0; modifications have been made.